SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001585364-19-000080
Filing Date
2019-08-08
Accepted
2019-08-08 07:49:26
Documents
16
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cy19q2earningsrelease8.htm   iXBRL 8-K 67079
2 EXHIBIT 99.1 cy19q2ex991pressrelease.htm EX-99.1 818814
8 image0a01a01a01a74.jpg GRAPHIC 16416
  Complete submission text file 0001585364-19-000080.txt   1097715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20190808.xsd EX-101.SCH 4579
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20190808_cal.xml EX-101.CAL 618
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20190808_def.xml EX-101.DEF 1468
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20190808_lab.xml EX-101.LAB 27015
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20190808_pre.xml EX-101.PRE 14036
9 EXTRACTED XBRL INSTANCE DOCUMENT cy19q2earningsrelease8_htm.xml XML 4543
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 191007500
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences